Clobazam for Refractory Childhood Seizure Disorders - A Valuable Supplementary Drug

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Volumn 15, Issue 4, 1988, Pages 406-408

  Munn, Robert ^a   Camfield, Peter ^a   Camfield, Carol ^a   Dooley, Joseph ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM;

CLINICAL ARTICLE; DRUG TOLERANCE; EPILEPSY; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE;

ADOLESCENT; ADULT; BENZODIAZEPINES; BENZODIAZEPINONES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; MALE; MENTAL RETARDATION; SEIZURES;

EID: 0024268715     PISSN: 03171671     EISSN: 20570155     Source Type: Journal    
DOI: 10.1017/S0317167100028146     Document Type: Article

References (14)

1. Farrell K. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 1986; 27(Suppl. 1): S45–S51.AMBIGUOUS (116 citations)
2. Jawad S, Richens A, Oxley J. Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. Br J Clin Pharmacol 1984; 18; 873–7. 6529527
3. Cano JP, Bun H, Iliadis A, Influence of anti-epileptic drugs on plasma levels of clobazam and desmethylclobazam: application of research on relations between doses, plasma levels and clinical efficacy, in: Hindmarch I, Stonier PD, eds. Clobazam International congress and symposium series, no. 43. London: Royal Society of Medicine 1981: 169–174.
4. Fielding A, Hoffmann I. Pharmacology of anti-anxiety drugs with special reference to clobazam. Br J Clin Pharmacol 1979; 7: 7S–15S.AMBIGUOUS (197 citations)
5. Koeppen D. A review of clobazam studies in epilepsy. in: Hindmarch I, Stonier PD, Trimble MR, eds. Clobazam: Human Psychopharmacology and Clinical Application. International congress and symposium series, no. 74. London: Royal Society of Medicine 1985: 207–15.
6. Tinuper P, Aguglia U, Gastaut H. Use of clobazam in certain forms of status epilepticus and in startle-induced epileptic seizures. Epilepsia 1986; 27(Suppl. 1): S18–S26.AMBIGUOUS (116 citations)
7. Gastaut H, Low MD. Antiepileptic properties of clobazam a 1,5 benzodiazepine, in man. Epilepsia 1979; 20: 437–46. 383476
8. Cull CA, Trimble MR. Anticonvulsant benzodiazepines and performance. in: Hindmarch I, Stonier PD, Trimble MR, eds. Clobazam: Human Psychopharmacology and Clinical Application. International congress and symposium series, no. 74. London: Royal Society of Medicine 1985: 121–8.
9. Kruse HJ. Psychopharmacology of clobazam with special reference to its anticonvulsant activity. in: Hindmarch I, Stonier PD, Trimble MR, eds. Clobazam: Human Psychopharmacology and Clinical Application. International congress and symposium series, no. 74. London: Royal Society of Medicine 1985: 113–20.
10. Robertson M. Current status of the 1,4 - and 1,5 - benzodiazepines in the treatment of epilepsy: the place of clobazam. Epilepsia 1986; 27(Suppl. 1): S27–S41.AMBIGUOUS (116 citations)
11. Gastaut H. The effect of benzodiazepines on chronic epilepsy in man (with particular reference to clobazam). in: Hindmarch I, Stonier PD, eds. Clobazam International congress and symposium, no. 43. London: Royal Society of Medicine 1981: 141–150.
12. Schmidt D, Rohde M, Wol P, Clobazam for refractory epilepsy, a controlled trial. Arch Neurol 1986; 43: 824–6. 3089202
13. Shimizu H, Abe J, Futagi Y, Antiepileptic effects of clobazam in children. Brain Dev 1982; 4: 57–62. 7039390
14. Dulac O, Figueroa D, Rey E, Monothérapie par le clobazam dans les épilepsies de l’enfant. Presse Méd 1983; 12: 1067–9.6221272